NextPlat (NXPL) Total Liabilities (2010 - 2026)
NextPlat's (NXPL) quarterly Total Liabilities came in at $12.2 million in Q2 2026, up 64.13% year-over-year from $7.4 million in Q2 2025, and up 17.82% quarter-over-quarter from $10.3 million in Q1 2026.
Analysis
NextPlat (NXPL) Total Liabilities (2010 - 2026) Analysis & Trends
NextPlat (NXPL) has reported Total Liabilities for 17 consecutive years, with $12.2 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Total Liabilities rose 64.13% year-over-year to $12.2 million in Q2 2026; TTM through Jun 2026 was $12.2 million, a 64.13% increase from a year earlier, with the FY2025 full-year figure at $10.0 million, up 3.75% from the prior year.
- Total Liabilities was $12.2 million for Q2 2026 at NextPlat, up from $10.3 million in the prior quarter.
- Over five years, Total Liabilities peaked at $18.0 million in Q1 2024 and troughed at $1.9 million in Q1 2022.
- A 5-year average of $8.9 million and a median of $9.7 million in 2024 frame the typical range for Total Liabilities.
- Across the five-year window, Total Liabilities surged 611.14% in 2023 and slumped 48.75% in 2025, its largest moves.
- Over 5 years, Total Liabilities stood at $2.9 million in 2022, then surged by 471.2% to $16.4 million in 2023, then tumbled by 40.91% to $9.7 million in 2024, then climbed by 3.75% to $10.0 million in 2025, then increased by 21.35% to $12.2 million in 2026.
- The last three Total Liabilities figures came in at $12.2 million (Q2 2026), $10.3 million (Q1 2026), and $10.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | 32.10 Bn |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | 20.78 Bn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | 1.99 Bn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | 3.74 Bn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 25.60 Bn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | 896.90 Mn |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | 1.78 Bn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | 975.61 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | 33.31 Mn |
| 10 | NextPlat | 24.77 Mn | 12.93 Mn | 4.69 Mn | 12.19 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.19 Mn |
| Mar 31, 2026 | 10.34 Mn |
| Dec 31, 2025 | 10.04 Mn |
| Sep 30, 2025 | 8.47 Mn |
| Jun 30, 2025 | 7.43 Mn |
| Mar 31, 2025 | 9.75 Mn |
| Dec 31, 2024 | 9.68 Mn |
| Sep 30, 2024 | 11.31 Mn |
| Jun 30, 2024 | 14.49 Mn |
| Mar 31, 2024 | 17.97 Mn |
| Dec 31, 2023 | 16.38 Mn |
| Sep 30, 2023 | 16.66 Mn |
| Jun 30, 2023 | 2.49 Mn |
| Mar 31, 2023 | 3.09 Mn |
| Dec 31, 2022 | 2.87 Mn |
| Sep 30, 2022 | 2.34 Mn |
| Jun 30, 2022 | 2.39 Mn |
| Mar 31, 2022 | 1.93 Mn |
| Dec 31, 2021 | 3.03 Mn |
| Sep 30, 2021 | 1.51 Mn |